SciELO - Scientific Electronic Library Online

 
vol.147 número5Receptores HER2, compromiso ganglionar axilar y sobrevida en mujeres con cáncer de mama ductal invasivoAdherencia terapéutica y control glucémico en pacientes con diabetes gestacional bajo dos esquemas de tratamiento índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista médica de Chile

versão impressa ISSN 0034-9887

Resumo

SOTO, Verónica et al. Radionuclide synoviorthesis in hemophilia: experience in 107 patients. Rev. méd. Chile [online]. 2019, vol.147, n.5, pp.568-573. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872019000500568.

Background:

In patients with hemophilia, radionuclide synoviorthesis, or the intra-articular injection of a radionuclide to decrease the synovial hypertrophy tissue, aims to decrease or avoid hemarthrosis.

Aim:

To evaluate the effectiveness of radionuclide synoviorthesis in hemophilia.

Material and Methods:

Observational retrospective study of the evolution of 107 male patients aged 3 to 54 years who were subjected to radionuclide synoviorthesis between 2007 and 2015.

Results:

Of 164 treated joints, in 65% treatment was successful, (defined as zero to two hemarthroses and absence of synovitis during the follow up period), in 17% it was partially successful (defined as two or less hemarthroses, but persistence of the synovitis) and failed in 18% of the procedures. No important complications were recorded.

Conclusions:

Radionuclide synoviorthesis has an overall 82% success rate, is minimally invasive, can be used at any age and is inexpensive We recommend its implementation in Chilean hemophilia treatment centers.

Palavras-chave : Hemarthrosis; Hemophilia; Synovitis.

        · texto em Espanhol     · Espanhol ( pdf )